# INBS (Intelligent Bio Solutions Inc.) - SEC EDGAR Financial Statements

> Intelligent Bio Solutions Inc. reported $4.50M in revenue and a net loss of $12.11M for the trailing twelve months ended September 30, 2026 (up 25.2% year over year), with a 50.9% gross margin and a -272.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/INBS
- Markdown: https://convexityos.com/fundamentals/INBS.md
- SEC CIK: 0001725430
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:08 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001725430&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $4.50M | +25.2% YoY |
| Operating Income | TTM | -$12.23M | -272.2% margin |
| Net Income | TTM | -$12.11M | -269.3% net margin |
| Diluted EPS | TTM | -$3.91 | Split-adjusted |
| Free Cash Flow | TTM | -$12.05M | -268.1% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $5.93M | Total debt: $1.79M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $4.22M | $3.05M | $3.11M | $1.26M | $437K | $1.98M | $189K |
| Cost of Revenue | $2.17M | $1.81M | $1.69M | $930K | -- | -- | -- |
| **Gross Profit** | $2.05M | $1.25M | $1.43M | $327K | -- | -- | -- |
| Selling, General & Admin | $10.50M | $8.92M | -- | -- | -- | -- | -- |
| Total Operating Expenses | $15.34M | $12.74M | $12.13M | $13.66M | $8.77M | $7.55M | $3.05M |
| **Operating Income** | -$12.61M | -$10.68M | -$10.28M | -$12.60M | -$8.34M | -$5.57M | -$2.86M |
| **EBITDA** | -$11.44M | -$9.71M | -$9.31M | -$11.78M | -$8.34M | -- | -- |
| Interest Income | $110K | $102K | $85K | -- | -- | -- | -- |
| Interest Expense | $11K | $26K | $167K | -- | -- | -- | -- |
| Income Before Tax | -- | -- | -- | -- | -- | -$7.06M | -$3.19M |
| **Net Income** | -$12.43M | -$10.57M | -$10.16M | -$10.63M | -$8.31M | -$7.04M | -$3.16M |
| Basic EPS | -$8.44 | -$20.04 | -$63.80 | -$1,270.00 | -$1,360.14 | -$1,632.65 | -$888.36 |
| **Diluted EPS** | -$8.44 | -$20.04 | -$63.80 | -$1,270.00 | -$1,360.14 | -$1,632.65 | -$888.36 |
| Basic Shares Outstanding | 1.5M | 527.4K | 159.3K | 8.4K | 6.1K | 4.3K | 3.5K |
| Diluted Shares Outstanding | 1.5M | 527.4K | 159.3K | 8.4K | 6.1K | 4.3K | 3.5K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.39M | $1.15M | $1.06M | $897K | $1.11M | $844K | $902K | $741K |
| Cost of Revenue | $634K | $609K | $525K | $437K | $594K | $508K | $387K | $384K |
| **Gross Profit** | $758K | $537K | $535K | $460K | $518K | $336K | $341K | $223K |
| Selling, General & Admin | $2.58M | $2.99M | $2.46M | $2.34M | $2.71M | -- | $2.41M | $1.81M |
| Total Operating Expenses | $3.65M | $4.75M | $3.65M | $3.17M | $3.71M | $3.83M | $3.07M | $2.62M |
| **Operating Income** | -$2.68M | -$3.97M | -$2.95M | -$2.64M | -$3.00M | -$3.11M | -$2.56M | -$2.26M |
| **EBITDA** | -$2.39M | -$3.68M | -$2.66M | -$2.35M | -$2.70M | -$2.86M | -$2.44M | -$1.90M |
| Interest Income | $21K | $47K | $49K | $5.3K | $8.5K | $9.1K | $18K | $22K |
| Interest Expense | $1.4K | $3.3K | $4.2K | $56K | $2.3K | $5.3K | $7.9K | $14K |
| **Net Income** | -$2.66M | -$3.91M | -$2.86M | -$2.68M | -$2.98M | -$3.09M | -$2.54M | -$2.25M |
| Basic EPS | -$0.86 | -- | -$1.80 | -$2.82 | -$3.49 | -- | -$4.41 | -$4.96 |
| **Diluted EPS** | -$0.86 | -- | -$1.80 | -$2.82 | -$3.49 | -- | -$4.41 | -$4.96 |
| Basic Shares Outstanding | 3.1M | -- | 1.6M | 950.8K | 854.7K | -- | 577.2K | 453.6K |
| Diluted Shares Outstanding | 3.1M | -- | 1.6M | 950.8K | 854.7K | -- | 577.2K | 453.6K |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.99M | $1.02M | $6.30M | $1.54M | $8.24M | $12.57M | $427K |
| **Cash & Short-Term Investments** | $3.99M | $1.02M | $6.30M | $1.54M | $8.24M | $12.57M | $427K |
| Accounts Receivable, Net | $848K | $595K | $430K | $294K | -- | -- | -- |
| Inventory | $419K | $635K | $778K | $980K | -- | -- | -- |
| Other Current Assets | $1.03M | $827K | $498K | $553K | $747K | $2.51M | $49K |
| **Total Current Assets** | $7.10M | $4.14M | $8.53M | $3.86M | $10.87M | $18.21M | $2.34M |
| Property, Plant & Equipment, Net | $294K | $251K | $566K | $690K | $391K | -- | -- |
| Intangible Assets | $2.80M | $3.79M | $4.37M | $5.26M | -- | -- | -- |
| Other Non-Current Assets | -- | -- | -- | -- | -- | $504K | -- |
| **Total Non-Current Assets** | $4.84M | $4.11M | $5.24M | $6.49M | $1.48M | $3.65M | $136K |
| **Total Assets** | $11.94M | $8.25M | $13.78M | $10.35M | $12.35M | $21.86M | $2.48M |
| Accounts Payable | $712K | $897K | -- | -- | $716K | $1.36M | $484K |
| **Total Current Liabilities** | $4.93M | $5.35M | $5.45M | $5.88M | $4.66M | $3.68M | $7.69M |
| **Total Non-Current Liabilities** | $1.72M | $85K | $145K | $784K | $1.14M | $3.17M | $0 |
| **Total Liabilities** | $6.65M | $5.44M | $5.60M | $6.67M | $5.81M | $6.85M | $7.69M |
| **Total Debt (incl. Leases)** | $1.82M | $85K | $356K | $580K | -- | -- | -- |
| Common Stock | $29K | $7.3K | $35K | $1.9K | $7.4K | $136K | $86K |
| Retained Earnings | -$74.96M | -$62.53M | -$51.96M | -$41.81M | -$31.18M | -$22.87M | -$15.83M |
| Accumulated Other Comp. Income | -$546K | -$328K | -$713K | -$575K | -$788K | -$661K | -$364K |
| **Total Stockholders' Equity** | $5.51M | $3.00M | $8.33M | $3.80M | $6.62M | $15.06M | -$5.19M |
| Total Equity | $5.29M | $2.81M | $8.18M | $3.69M | $6.55M | $15.01M | -$5.21M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.93M | $3.99M | $6.86M | $740K | $1.66M | $1.02M | $2.81M | $2.24M |
| **Cash & Short-Term Investments** | $5.93M | $3.99M | $6.86M | $740K | $1.66M | $1.02M | $2.81M | $2.24M |
| Accounts Receivable, Net | $1000K | $848K | $878K | $457K | $718K | $595K | $511K | $266K |
| Inventory | $478K | $419K | $597K | $590K | $628K | $635K | $683K | $701K |
| Other Current Assets | $1.11M | $1.03M | -- | $480K | $488K | $827K | $585K | $349K |
| **Total Current Assets** | $9.05M | $7.10M | $9.75M | $12.17M | $4.48M | $4.14M | $5.11M | $4.06M |
| Property, Plant & Equipment, Net | $278K | $294K | $312K | $322K | $272K | $251K | $546K | $537K |
| Intangible Assets | $2.60M | $2.80M | $3.00M | $3.27M | $3.47M | $3.79M | $3.80M | $3.90M |
| **Total Non-Current Assets** | $4.58M | $4.84M | $5.11M | $5.48M | $5.55M | $4.11M | $4.48M | $4.62M |
| **Total Assets** | $13.62M | $11.94M | $14.86M | $17.65M | $10.04M | $8.25M | $9.58M | $8.68M |
| Accounts Payable | -- | $712K | -- | -- | -- | $897K | -- | -- |
| **Total Current Liabilities** | $4.58M | $4.93M | $4.61M | $5.13M | $5.06M | $5.35M | $4.56M | $4.40M |
| **Total Non-Current Liabilities** | $1.69M | $1.72M | $1.50M | $1.64M | $1.55M | $85K | $76K | $78K |
| **Total Liabilities** | $6.27M | $6.65M | $6.11M | $6.76M | $6.61M | $5.44M | $4.64M | $4.48M |
| **Total Debt (incl. Leases)** | $1.79M | $1.82M | $1.85M | $1.91M | $1.81M | $85K | $155K | $220K |
| Common Stock | $33K | $29K | $20K | $12K | $91K | $7.3K | $68K | $48K |
| Retained Earnings | -$77.62M | -$74.96M | -$71.06M | -$68.19M | -$65.52M | -$62.53M | -$59.44M | -$56.90M |
| Accumulated Other Comp. Income | -$598K | -$546K | -$500K | -$266K | -$279K | -$328K | -$523K | -$639K |
| **Total Stockholders' Equity** | $7.58M | $5.51M | $8.96M | $11.09M | $3.62M | $3.00M | $5.11M | $4.37M |
| Total Equity | $7.35M | $5.29M | $8.75M | $10.89M | $3.43M | $2.81M | $4.94M | $4.20M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$12.47M | -$10.60M | -$10.19M | -$10.66M | -$8.33M | -$7.06M | -$3.19M |
| Depreciation & Amortization | $1.16M | $970K | $974K | $814K | $0 | -- | -- |
| Stock-Based Compensation | $195K | $238K | $230K | $260K | -- | -- | -- |
| Change in Receivables | -$254K | -$165K | -$136K | -$294K | $1.83M | -- | -- |
| Change in Inventory | $217K | $142K | $202K | -$345K | -- | -- | -- |
| Change in Payables | -- | -- | -- | -- | -- | $783K | -$350K |
| **Operating Cash Flow** | -$11.93M | -$9.68M | -$9.57M | -$7.38M | -$3.36M | -$11.30M | -$499K |
| Capital Expenditure | -$126K | -$232K | -$221K | -- | -- | -- | -- |
| **Free Cash Flow** | -$12.05M | -$9.91M | -$9.79M | -- | -- | -- | -- |
| Acquisitions, Net | -- | -- | -- | -$364K | -- | -- | -- |
| **Investing Cash Flow** | -$86K | -$232K | -$221K | -$694K | -$880K | -- | -$14K |
| Common Stock Issued | -- | -- | -- | -- | -- | $508K | -- |
| **Financing Cash Flow** | $14.98M | $4.60M | $14.56M | $1.44M | -- | $23.40M | $734K |
| **Net Change in Cash** | $2.97M | -$5.28M | $4.77M | -$6.70M | -$4.34M | $12.15M | $229K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.67M | -$3.92M | -$2.87M | -$2.69M | -$2.99M | -$3.10M | -$2.55M | -$2.26M |
| Depreciation & Amortization | $294K | $288K | $290K | $282K | $303K | $244K | $115K | $369K |
| Stock-Based Compensation | $98K | $97K | $24K | $62K | $12K | $12K | $12K | $12K |
| Change in Receivables | -$151K | $30K | -$422K | $261K | -$123K | -$84K | -$245K | $312K |
| Change in Inventory | -$59K | $179K | -$7.2K | $38K | $7.0K | $48K | $18K | $38K |
| **Operating Cash Flow** | -$2.75M | -$3.18M | -$4.33M | -$1.57M | -$2.85M | -$2.21M | -$2.76M | -$2.32M |
| Capital Expenditure | -- | $0 | $13K | -$68K | -$70K | -- | -- | -- |
| **Free Cash Flow** | -- | -$3.18M | -$4.32M | -$1.64M | -$2.92M | -- | -- | -- |
| **Investing Cash Flow** | -- | $0 | $13K | -$28K | -$70K | -- | -- | -- |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | $810K | $677K |
| **Financing Cash Flow** | $4.68M | $312K | $10.44M | $675K | $3.56M | $602K | $3.32M | $632K |
| **Net Change in Cash** | $1.94M | -$2.87M | $6.12M | -$920K | $640K | -$1.79M | $565K | -$1.75M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 48.6% | 40.8% | 45.8% | 26.0% | -- | -- | -- |
| **Operating Margin** | -299.1% | -349.8% | -330.5% | -1002.1% | -1907.1% | -281.4% | -1513.7% |
| **Net Profit Margin** | -294.9% | -346.2% | -326.4% | -845.9% | -1900.1% | -355.3% | -1676.2% |
| Return on Equity (ROE) | -225.6% | -352.7% | -121.9% | -279.9% | -125.4% | -46.7% | -- |
| Return on Assets (ROA) | -104.1% | -128.1% | -73.7% | -102.7% | -67.2% | -32.2% | -127.8% |
| Current Ratio | 1.44x | 0.77x | 1.57x | 0.66x | 2.33x | 4.94x | 0.30x |
| Quick Ratio | 1.35x | 0.65x | 1.42x | 0.49x | 1.77x | 3.41x | 0.06x |
| Debt to Equity | 0.33x | 0.03x | 0.04x | 0.15x | -- | -- | -- |
| **Revenue Growth (YoY)** | +38.1% | -1.9% | +147.6% | +187.5% | -77.9% | +949.3% | -- |
| Gross Profit Growth (YoY) | +64.4% | -12.5% | +336.4% | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -99.4% | -89.1% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 50.9% | 48.6% | 47.2% | 44.1% | 39.4% | 35.8% | 51.2% | 46.3% |
| **Operating Margin** | -272.2% | -297.8% | -298.7% | -301.1% | -303.8% | -305.7% | -307.5% | -318.7% |
| **Net Profit Margin** | -269.3% | -294.9% | -296.8% | -300.8% | -301.9% | -303.2% | -304.6% | -316.9% |
| Return on Equity (ROE) | -159.7% | -225.6% | -129.6% | -101.8% | -300.1% | -352.7% | -200.7% | -245.0% |
| Return on Assets (ROA) | -88.9% | -104.1% | -78.1% | -64.0% | -108.2% | -128.1% | -107.1% | -123.2% |
| Current Ratio | 1.98x | 1.44x | 2.11x | 2.37x | 0.89x | 0.77x | 1.12x | 0.92x |
| Quick Ratio | 1.87x | 1.35x | 1.98x | 2.26x | 0.76x | 0.65x | 0.97x | 0.76x |
| Debt to Equity | 0.24x | 0.33x | 0.21x | 0.17x | 0.50x | 0.03x | 0.03x | 0.05x |
| **Revenue Growth (YoY)** | +25.2% | +35.8% | +17.6% | +21.0% | +11.4% | +15.9% | -0.6% | -19.2% |
| Gross Profit Growth (YoY) | +46.3% | +59.9% | +56.8% | +106.1% | +49.4% | -58.9% | +91.3% | +12.0% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
